Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
“In addition, genistein promoted an increased response to a third exposure to the agonist when applied after washing the cells that had been previously challenged with two increasing doses of bradykinin.”
Journal of cellular biochemistry • 2000 | View Paper
“Our results suggest that the down-regulation of ACE with a consequent change in the circulating levels of angiotensin II (Ang II), vasorelaxant angiotensin-(1-7) [Ang-(1-7)] and bradykinin plays an important role in cardiovascular effects of genistein through the ERK1/2 pathway.”
“On the other hand, genistein (a tyrosine kinase inhibitor) was able to inhibit thapsigargin (3.12 ± 0.22, n = 5, vs. 1.28 ± 0.16, n = 4, p < 0.001) as well as BK responses (6.46 ± 0.66 vs. 2.89 ± 0.61, n = 4, p < 0.05).”
“Tyrphostine A23 and genistein (tyrosine kinase inhibitors) decreased the bradykinin (10 n M)-induced IP3 production potentiated by 2 n M insulin from 400.7 ± 19.4 pmol/mg protein to 297.3 ± 42.4 and 314.3 ± 37.5 pmol/mg protein, respectively.”
The American journal of physiology • 1998 | View Paper
“ Genistein , an inhibitor of tyrosine kinase, did not affect baseline diameter of the basilar artery but inhibited vasodilatation in response to acetylcholine and bradykinin , without affecting vasodilatation produced by sodium nitroprusside.”